WHO list reveals flu advisors with financial ties to pharma, vaccine manufacturers

Natural News
Aug 12, 2010

After months of stalling, the World Health Organization (WHO) has finally revealed the names of key pandemic advisors who influenced its decision to declare a phase six pandemic last year — a decision that resulted in a financial windfall for vaccine manufacturers. As you’ll see here, that list includes at least five expert advisors received money from vaccine companies.

Here’s who received money from Big Pharma and then influenced the WHO decision to declare a pandemic:

Arnold Monto is a professor from the United States who has received money from virtually all the major vaccine manufacturers: GSK, Novartis, Roche, Baxter and Sanofi Pasteur. He has specifically been given grant money by Sanofi Pasteur to study influenza vaccines.

Nancy Cox works for the US Centers for Disease Control, which already maintains a pro-vaccine stance while utterly ignoring the importance of vitamin D in halting infectious disease. Nancy took funds from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) to conduct work on vaccines.

John Wood works at Britain’s National Institute for Biological Standards and Control (NIBSC). They’ve taken money from Sanofi Pasteur, Novartis and several other companies focused on influenza vaccine research.

Maria Zambon is a professor at the UK Health Protection Agency Centre for Infection. She has received money from Sanofi, Novartis, CSL, Baxter and GSK.

Neil Ferguson is also a professor, and he has accepted money from Roche and GSK Biologicals.

There may be more to this story, too: The financial ties explained here are merely the ones that these people chose to publicly disclose to WHO. There may yet be other ties that currently remain a secret and will have to be dug up by some determined reporte

What’s the problem with financial ties, anyway?

Why does it matter that WHO advisors took money from vaccine companies? It’s simple: The decision to declare H1N1 swine flu to be a phase 6 pandemic was made by the WHO under advisement from these very people who received money from vaccine companies. And that decision, we now know, resulted in a windfall of profits for the vaccine companies.

Those profits, in turn, were burdened by the taxpayers whose expenditures were largely worthless because a huge portion of those vaccines are now expiring and have to be destroyed. The money was wasted, in other words.

It all has the makings of a grand global con: The WHO enlists advisors with financial ties to the vaccine industry to decide whether a pandemic is under way and then conveniently follows their advice in making a decision that many health experts around the world have been questioning from the start. It all has the appearance of medical corruption, and it looks like WHO decisions are based more on politics than medical science.

It was politically convenient, in other words, to declare a stage six pandemic. And if these WHO advisors have already received money from vaccine manufacturers, it’s certainly within the realm of possibility that they would soon be financially rewarded with yet more payoffs. (You scratch my back and I’ll scratch yours…)

The appearance of corruption

The unfortunate upshot of all this is that even if these WHO advisors are completely innocent, their financial ties still create the appearance of corruption. And that means the WHO is losing credibility that may compromise its integrity when a real pandemic comes along. If the world can’t trust the World Health Organization, in other words, then who should countries look to for real answers on pandemics and infectious disease?

Sadly, even the CDC in the US has now clearly positioned itself as an “anti-nutrition, pro-vaccine” organization, too. Ignoring the huge importance of vitamin D and the support of the human immune system, many CDC experts have also either been on the payrolls of vaccine manufacturers or are looking to join Big Pharma when offered a job. The former head of the CDC, Dr. Julie Gerberding, was recently offered a position as the president of Merck’s vaccine division (http://www.naturalnews.com/027789_D…).

The frustrating fact is that modern medicine has been subverted by Big Pharma. The vaccine industry practically runs the CDC and WHO — or at the very least, it heavily influences decisions by these two organizations. As a result, the so-called “scientific” decisions made by these organizations have very little to do with actual science but everything to do with protecting (and expanding) the profits of vaccine manufacturers.

And when public health policy is decided based on corporate profits, the people will always suffer.

Did you notice that the list of WHO advisors did not include even a single naturopathic physician? Not a single holistic nutritionist? There was nobody on the board that brought a pro-nutrition point of view to the discussions. And you know why nutritionists and naturopaths weren’t invited to join the WHO advisory board? Because the WHO has already pre-decided it doesn’t want to hear those points of view. It has stubbornly decided to entertain only vaccines as the solution to virtually all infectious disease.

And if you only invite vaccine pushers to the table, guess what kind of advice you’re going to get? “Push more vaccines!”

Asking a bunch of vaccine experts whether you should declare a pandemic is sort of like asking your insurance agent whether you need more insurance. Well of course you do!

No wonder the WHO has lost so much credibility. It refuses to look at real solutions that might work for poor nations (such as low-cost vitamin D supplements) while strongly favoring the high-profit operations of the vaccine industry. That’s why the WHO simply can’t be trusted anymore. It has now become a pawn of the pharmaceutical industry that will always make decisions that favor the financial interests of Big Pharma.

See the WHO list of advisors here:
http://www.who.int/ihr/emerg_comm_m…

WHO releases names of experts and advisor to the Emergency Committee concerning Influenza Pandemic (H1N1) 2009
Submitted by thiru on 11. August 2010 – 2:09
Baxter GSK H1N1 IFPMA novartis Roche Sanofi-Pasteur WHO
WHO has released the ‘List of Members of, and Advisor to, the International Health Regulations (2005) Emergency Committee concerning Influenza Pandemic (H1N1) 2009’ at the following site: http://www.who.int/ihr/emerg_comm_members_2009/en/. Of the 15 members and one advisor, 6 had declaration of interests. On this matter, WHO had the following statement:
The interests summarized above do not give rise to a conflict of interest such that the experts concerned should be partially or totally excluded from participation in the Emergency Committee. However, following WHO’s policy, they were disclosed within the Committee so that other members were aware of them. All other Members of the Emergency Committee declared no relevant interests.
Here are the following declarations of interest taken directly from the WHO website.
Declaration of Interests
Dr Nancy Cox
Her public health and surveillance research unit at the US Centers for Disease Control & Prevention (CDC) receives financial support from IFPMA for activities of CDC as a WHO Collaborating Centre in the field of influenza vaccine research and virus isolation work.
Professor Arnold Monto
He has declared current and past consultancies in the field of pandemic and/or seasonal influenza for GSK, Novartis, Roche, Baxter and Sanofi. The remuneration for each of these consultancies is below US$10 000. In addition, his research unit at the University of Michigan has received a grant from Sanofi Pasteur for a clinical trial conducted in 2007-2008 on the comparative efficacy of inactivated and live attenuated influenza vaccines.
Dr Claude Thibeault
Since 2004, he is the Consultant Medical Advisor to International Air Transport Association.
Dr John Wood
His research unit at the National Institute for Biological Standards and Control (NIBSC), a centre of the UK Health Protection Agency, has performed contract research for Sanofi Pasteur, CSL, IFPMA, Novartis and Powdermed in the field of influenza vaccine research and development.
Professor Maria Zambon
The UK Health Protection Agency Centre for Infection receives funding from vaccine manufacturers, including Sanofi, Novartis, CSL, Baxter and GSK, for contract work in Dr Zambon’s laboratory.
Professor Neil Morris Ferguson (Advisor)
He has acted as a consultant for Roche and GSK Biologicals (ceasing in 2007), with total remuneration from all such work being under US$7 000 in 2007.
Here below is the comprehensive list of experts and advisor to the Committee (Source: http://www.who.int/ihr/emerg_comm_members_2009/en/).
List of Members of, and Advisor to, the International Health Regulations (2005) Emergency Committee concerning Influenza Pandemic (H1N1) 2009
Members
Dr Lawson Ahadzie
Former Head of Surveillance Department, Ghana Health Service/Ministry of Health, Accra, Ghana (Dr Ahadzie’s membership was suspended after the fifth Emergency Committee Meeting on becoming a WHO staff member)
Mr André Basse
Counsellor, Embassy of Senegal, Paris, France
Dr Muhammad Akbar Chaudhry
Principal, Professor of Medicine, Fatima Jinnah Medical College, Lahore, Pakistan (Dr Chaudry’s membership commenced with the sixth Emergency Committee Meeting)
Dr Supamit Chunssuttiwat
Senior Expert in Disease Control, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand
Dr Nancy Cox
Director, Influenza Division, Centers for Disease Control and Prevention, Atlanta, USA
Dr Anthony Evans
Chief, Aviation Medicine Section, International Civil Aviation Organization, Montreal, Canada
Professor John Mackenzie
Professor of Tropical Infectious Diseases, Division of Health Sciences, Curtin University, Perth, Australia
Professor Arnold Monto
Professor, Department of Epidemiology, University of Michigan, Ann Arbor, USA
Dr Fernando Otaiza
Coordinator, National Infection Control Program, Ministry of Health, Santiago, Chile
Dr Rogelio Pérez Padilla
Director General, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico
Dr Wing Hong Seto
Chief of Service, Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China
Dr Masato Tashiro
Director, Department of Viral Diseases and Vaccine Control, National Institute of Infectious Diseases, Tokyo, Japan
Dr Claude Thibeault
Consultant in Aviation Medicine and Occupational Health, Montreal, Canada
Dr John Wood
Principal Scientist, Division of Virology, National Institute for Biological Standards and Control, Herts, United Kingdom
Professor Maria Zambon
Head of Respiratory Virus Unit, Virus Reference Department, Health Protection Agency, Centre for Infection, London, United Kingdom
Advisor to the Emergency Committee
Professor Neil Morris Ferguson
Chair in Mathematical Biology, Department of Infectious Disease Epidemiology, Imperial College Faculty of Medicine, London, United Kingdom
Declaration of Interests
Dr Nancy Cox
Her public health and surveillance research unit at the US Centers for Disease Control & Prevention (CDC) receives financial support from IFPMA for activities of CDC as a WHO Collaborating Centre in the field of influenza vaccine research and virus isolation work.
Professor Arnold Monto
He has declared current and past consultancies in the field of pandemic and/or seasonal influenza for GSK, Novartis, Roche, Baxter and Sanofi. The remuneration for each of these consultancies is below US$10 000. In addition, his research unit at the University of Michigan has received a grant from Sanofi Pasteur for a clinical trial conducted in 2007-2008 on the comparative efficacy of inactivated and live attenuated influenza vaccines.
Dr Claude Thibeault
Since 2004, he is the Consultant Medical Advisor to International Air Transport Association.
Dr John Wood
His research unit at the National Institute for Biological Standards and Control (NIBSC), a centre of the UK Health Protection Agency, has performed contract research for Sanofi Pasteur, CSL, IFPMA, Novartis and Powdermed in the field of influenza vaccine research and development.
Professor Maria Zambon
The UK Health Protection Agency Centre for Infection receives funding from vaccine manufacturers, including Sanofi, Novartis, CSL, Baxter and GSK, for contract work in Dr Zambon’s laboratory.
Professor Neil Morris Ferguson (Advisor)
He has acted as a consultant for Roche and GSK Biologicals (ceasing in 2007), with total remuneration from all such work being under US$7 000 in 2007.
The interests summarized above do not give rise to a conflict of interest such that the experts concerned should be partially or totally excluded from participation in the Emergency Committee. However, following WHO’s policy, they were disclosed within the Committee so that other members were aware of them. All other Members of the Emergency Committee declared no relevant interests.